Immune Biosolutions is a clinical-stage biotechnology company specializing in the discovery and engineering of avian and human antibodies for therapeutic applications. Utilizing cutting-edge technologies, we develop custom immunotherapeutic agents. Our discovery platform efficiently targets complex proteins and generate powerful, specific, and innovative antibodies. Additionally, our antibody production capability allows us to advance our own discovery programs in cancer and autoimmune diseases into the early phases of clinical development.
Looking for a particular Immune Biosolutions inc. employee's phone or email?
Immune Biosolutions inc. Questions
The Immune Biosolutions inc. annual revenue was $6.4 million in 2026.
Bruno Maranda is the CEO of Immune Biosolutions inc..
14 people are employed at Immune Biosolutions inc..
Immune Biosolutions inc. is based in Sherbrooke, Quebec.
The NAICS codes for Immune Biosolutions inc. are [541, 54, 541713, 5417, 54171].
The SIC codes for Immune Biosolutions inc. are [87, 873].
Top Immune Biosolutions inc. Employees
-
Bruno Maranda
Chief Executive Officer at Immune Biosolutions inc.
Sherbrooke, QC, CA21 -
34
-
Djordje Grbic
Directeur Biofabrication at Immune Biosolutions inc.
Sherbrooke, QC, CA -
1 -
Martin Cloutier
Scientifique at Immune Biosolutions inc.
Sherbrooke, QC, CA -
Dominique Pellerin
Scientifique II at Immune Biosolutions inc.
Drummondville, QC, CA1 -
Catherine Duclos
Research Scientist II at Immune Biosolutions inc.
Sherbrooke, QC, CA -
Annie Leroux
Directrice des opérations at Immune Biosolutions inc.
Sherbrooke, QC, CA
Related Companies
